Paul Simon Freemont
Fondatore presso Equinox Pharma Ltd.
Profilo
Paul Simon Freemont is the founder of Equinox Pharma Ltd., which was founded in 2002.
He holds the title of Non-Executive Director at Equinox Pharma Ltd.
Dr. Freemont's current job is Director-EPSRC Centre at Imperial College London.
He is also a Director at Solena Materials Ltd.
since 2021.
Dr. Freemont's former job was as a Principal at Cancer Research UK.
He completed his undergraduate degree at the University of Aberdeen in 1984.
Posizioni attive di Paul Simon Freemont
Società | Posizione | Inizio |
---|---|---|
Equinox Pharma Ltd.
Equinox Pharma Ltd. Pharmaceuticals: MajorHealth Technology Equinox Pharma Ltd. provides informatics products and services used in the discovery and development of drugs. Its services include input screening data, rule-based model, predict a ranked list of active compounds and data source services. The company was founded on November 20, 2002 by Stephen Howard Muggleton, Michael Joseph Ezra Sternberg and Paul Simon Freemont and is headquartered in London, the United Kingdom. | Fondatore | 08/01/2010 |
Imperial College London | Corporate Officer/Principal | - |
Solena Materials Ltd.
Solena Materials Ltd. Miscellaneous Commercial ServicesCommercial Services Solena Materials Ltd. is a protein materials design British company that uses computational design, machine learning, and automation to develop bespoke materials for various sectors, including fashion apparel and medical textiles. The private company is based in London, UK. The company's protein-based fibers aim to replace materials extracted from nature and petrochemically-derived materials to create biodegradable, functional, and sustainable smart materials. The company was founded in 2021 by Jens Klein and James Tomomi Macdonald, with Jens Klein serving as the CEO since then. | Direttore/Membro del Consiglio | 23/07/2021 |
Precedenti posizioni note di Paul Simon Freemont
Società | Posizione | Fine |
---|---|---|
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Paul Simon Freemont
University of Aberdeen | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Commercial Services |
Equinox Pharma Ltd.
Equinox Pharma Ltd. Pharmaceuticals: MajorHealth Technology Equinox Pharma Ltd. provides informatics products and services used in the discovery and development of drugs. Its services include input screening data, rule-based model, predict a ranked list of active compounds and data source services. The company was founded on November 20, 2002 by Stephen Howard Muggleton, Michael Joseph Ezra Sternberg and Paul Simon Freemont and is headquartered in London, the United Kingdom. | Health Technology |
Solena Materials Ltd.
Solena Materials Ltd. Miscellaneous Commercial ServicesCommercial Services Solena Materials Ltd. is a protein materials design British company that uses computational design, machine learning, and automation to develop bespoke materials for various sectors, including fashion apparel and medical textiles. The private company is based in London, UK. The company's protein-based fibers aim to replace materials extracted from nature and petrochemically-derived materials to create biodegradable, functional, and sustainable smart materials. The company was founded in 2021 by Jens Klein and James Tomomi Macdonald, with Jens Klein serving as the CEO since then. | Commercial Services |
- Borsa valori
- Insiders
- Paul Simon Freemont